BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• IRLAB to present at Pareto Securities’ Healthcare Conference in Stockholm on September 14, 2023

  IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will participate at Pareto Securities’ 14th Annual Healthcare Conference on Thursday, September 14, 2023, in Stockholm, Sweden.

  September 13, 2023

   · 

  1 min read
• Business

  Poolbeg Pharma PLC Announces Interim Results for the Six Months to 30 June 2023

  Poolbeg Pharma announces its unaudited interim results for the six months to 30 June 2023.

  September 13, 2023

   · 

  5 min read
• Policy

  Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval

  Rentschler Biopharma SE announced that it has received the cGMP Manufacturing Compliance Certificate, following the successful inspection by the UK Medicines & Healthcare Products Regulatory Agency at its UK site.

  September 13, 2023

   · 

  3 min read
• Business

  Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update

  Ryvu Therapeutics reported financial results for the first half of 2023 and provided a corporate update.

  September 13, 2023

   · 

  8 min read
• Immuron achieves record monthly Travelan® sales

  Immuron Limited is pleased to announce record monthly sales of its over-the-counter gastrointestinal and digestive health immune supplement Travelan®.

  September 13, 2023

   · 

  3 min read
• Biotech Bay

  Subtle Medical Awarded $2.3M SBIR Grant to Expand Innovation in AI-powered Synthetic Imaging

  Subtle Medical was awarded a federal SBIR grant from the National Institutes of Health to expand their artificial intelligence -powered software solution, SubtleSYNTH™, which uses deep learning to synthesize Magnetic Resonance Imaging contrasts from already-acquired contrasts.

  September 13, 2023

   · 

  3 min read
• Pharm Country

  DolCas Biotech Obtains its First Non-GMO Project Verified Label for MMP-50®

  DolCas Biotech, LLC obtains its first Non-GMO Project-verified label for MMP-50®, a cold-processed, DNA-verified, and clinically researched New England green lipped mussel extract for human and pet health.

  September 13, 2023

   · 

  4 min read
• ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant to Advance GPR35 Inhibitor Program for Treatment of Gastrointestinal Disease and Cancers

  ThirtyFiveBio Limited today announced that the company has been awarded a highly competitive Biomedical Catalyst (BMC) grant from Innovate UK, the UK’s innovation agency.

  September 13, 2023

   · 

  4 min read
• Business

  Alex Gorsky Joins Neurotech’s Board as Lead Director

  Neurotech Pharmaceuticals, Inc., a private clinical stage biotech company, announced today that Alex Gorsky has been elected to Neurotech’s board as Lead Director.

  September 13, 2023

   · 

  3 min read
• Drug Development

  Asieris Announces Positive Interim Analysis Results in Phase II Clinical Trial of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer

  Asieris Pharmaceuticals announced that the clinical trial of oral APL-1202 in combination with PD-1 inhibitor Tislelizumab as neoadjuvant therapy for muscular invasive bladder cancer (MIBC) completed the phase II interim analysis with positive results.

  September 13, 2023

   · 

  4 min read